far.mar.sie. SRL
The score of far.mar.sie. shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
far.mar.sie.'s annual accounts
| 2025 | |
|---|---|
| Net result | 22,569 € |
| Equity | 24,569 € |
| Cash | 37,504 € |
| EBITDA | 28,587 € |
| Total assets | 48,660 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Aug 2026
far.mar.sie.'s financial analysis
- Solvency50.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of far.mar.sie.
far.mar.sie.'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1024.339.103
- VAT number
- BE1024339103
- Peppol
- Registered · 0208:1024339103 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Jun 2025
- Registered office
- 3512 Hasselt
- Latest accounts
- 2025 · filed on 30 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
far.mar.sie. (SRL) has been based in Hasselt since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 22,569 € and equity of 24,569 €; its revenue is not published. Its solvency stands at 50.5%, above the median of its sector (44.2%).
Companies similar to far.mar.sie.
Companies in the same business, of comparable size and area, outside its group.
- Apotheek BAKELANTS Retail sale of pharmaceutical products Geel · balance sheet €1.18m
- B.D. Farma Retail sale of pharmaceutical products Zwalm · balance sheet 562,484 €
- Pharmacie du Parc Astrid Retail sale of pharmaceutical products Anderlecht · balance sheet 342,276 €
- Sego Pharma Retail sale of pharmaceutical products Dessel · balance sheet 939,072 €
- Instapharma Retail sale of pharmaceutical products Antwerp · balance sheet €2.12m
- Vandewalle-Verrue Retail sale of pharmaceutical products Vleteren · balance sheet €2.33m
- PMI Construction Retail sale of pharmaceutical products Arlon · balance sheet 11,405 €
- Tannhauser Pharaescos Retail sale of pharmaceutical products Koekelberg · balance sheet 292,153 €
Frequently asked questions about far.mar.sie.
What is the revenue of far.mar.sie.?
far.mar.sie. files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of far.mar.sie.?
In Belgium, the VAT number is the company number prefixed with BE: BE1024339103 for far.mar.sie., if the company is VAT-registered. Its company number (CBE) is 1024.339.103.
Where is the registered office of far.mar.sie.?
According to the CBE register, the registered office of far.mar.sie. is in 3512 Hasselt.
What is the equity of far.mar.sie.?
At the close of the 2025 financial year, the equity of far.mar.sie. amounts to 24,569 €, a solvency of 50.5% of total assets.
Who manages far.mar.sie.?
The register lists 1 active mandates at far.mar.sie.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of far.mar.sie.
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →